REGASK SPONSORS
Regulatory Intelligence (RegIntel) Conference Europe 2025
NOVEMBER 3-4, 2025 | london, uk
Hilton London Wembley
Meet our team
Join Deanna Coscia, Senior Vice President, Commercial, and Oliver Stein, Business Development Director, as they represent RegASK at the Regulatory Intelligence (RegIntel) Conference Europe 2025.
Connect with our team to explore how AI-driven regulatory intelligence is transforming compliance and discover how RegASK empowers smarter, faster regulatory decisions in today’s dynamic and evolving life sciences landscape.
Deanna Coscia
SVP, Commercial
Oliver Stein
Business Development Director
Regulatory Intelligence (RegIntel) Conference Europe 2025
The Regulatory Intelligence (RegIntel) Conference Europe 2025, co-hosted by RAPS and TOPRA, is a premier event designed to empower regulatory professionals with the foresight needed in today’s rapidly evolving healthcare landscape. This conference offers a comprehensive exploration of the most pressing regulatory intelligence topics, equipping attendees with actionable insights to navigate complex compliance challenges.
Key Themes Include:
- Transforming regulatory data into strategic intelligence
- Addressing the impact of new technologies and evolving compliance standards
- Enhancing decision-making processes in a dynamic regulatory environment
- Networking opportunities with industry leaders and peers
Venue & Schedule:
📍 Table 2 | Hilton London Wembley, Lakeside Way, Wembley HA9 0BU, United Kingdom
🗓 November 3–4, 2025 | 09:30 – 19:00 BST
What RegASK Brings to the Regulatory Intelligence (RegIntel) Conference Europe 2025
At RegASK, we’re transforming the way regulatory teams navigate complexity through AI-driven intelligence and workflow orchestration. Our solutions enable organizations to monitor evolving global regulations, streamline global-to-local workflows, and make faster, data-informed compliance decisions with confidence.
Connect with our team at RegIntel Europe 2025 to discover how RegASK empowers regulatory professionals to stay ahead of change and shape smarter, more agile compliance strategies.
Our solution
RegASK leverages advanced AI and machine learning to help businesses in highly regulated industries streamline their regulatory compliance processes and stay ahead of the curve. Our cutting-edge solution automates regulatory research, provides vital insights, and empowers regulatory affairs teams to become strategic partners in driving business growth.
RegGenius
Harness the power of AI to gain a competitive edge in regulatory compliance.
RegAlert
No surprises with automated regulatory monitoring.
RegInsights
Identify trends, anticipate risks, and build better strategies.
Ask RegASK
Access to our community of regulatory subject matter experts.
Resources
Navigating a Potential U.S. Government Shutdown: Implic…
As legislators in Washington, DC, face a critical March 14th deadline to finalize federal spending, the possibility of a U.S. government shu…
Read more
RegASK Featured in Gartner’s Market Guide for Regulat…
We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …
Read more
The 2025 State of Regulatory Affairs and Compliance Rep…
Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more complex than ever, with new adv…
Read more
ANSM (France) Clarifies CE Mark Exemption Process for M…
On January 27, 2025, the National Security Agency of Medicines and Health Products (ANSM) in France issued a key update regarding the proces…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Establishes New Center for Real-World Evidenc…
On December 12, 2024, the U.S. Food and Drug Administration (FDA) announced the creation of the Center for Real-World Evidence and Innovatio…
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more